Dr. Gary Gabriels

Gary Gabriels is a South African health sciences researcher whose work centers on nutritional supplements, regulatory policy, and toxicological risk assessment. Affiliated with academic institutions in South Africa, his scholarship bridges public health, clinical practice, and laboratory science, with a strong focus on consumer protection and evidence-based regulation of supplement products.

His research critically examines supplement labeling, marketing claims, and legislative frameworks, highlighting gaps in oversight and the implications for athletes and the general public. Through survey-based studies and policy analyses, he has explored consumer attitudes, purchasing behavior, and the need for structured education and regulatory reform within the supplement industry.

Gabriels has also conducted laboratory investigations into adulterants such as melamine and fluoxetine, as well as computational toxicology studies on nephrotoxic mechanisms. This combination of analytical chemistry, in silico modeling, and pharmacoepidemiological insight underscores a key strength: integrating molecular evidence with public health advocacy to inform safer clinical assessment and consumer practices.